about
IrAE – An asparaginyl endopeptidase (legumain) in the gut of the hard tick Ixodes ricinusStructure of an Fab–Protease Complex Reveals a Highly Specific Non-canonical Mechanism of InhibitionA Reverse Binding Motif That Contributes to Specific Protease Inhibition by AntibodiesSmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoniIrCL1 - the haemoglobinolytic cathepsin L of the hard tick, Ixodes ricinus.Interference with heme binding to histidine-rich protein-2 as an antimalarial strategy.Positional scanning synthetic combinatorial libraries for substrate profiling.Characterization of proteinases from the midgut of Rhipicephalus (Boophilus) microplus involved in the generation of antimicrobial peptides.Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates.The functional expression and characterisation of a cysteine peptidase from the invasive stage of the neuropathogenic schistosome Trichobilharzia regentiThe androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.Half-life extension of the HIV-fusion inhibitor peptide TRI-1144 using a novel linker technology.Heme binding to the histidine-rich protein II from Plasmodium falciparum.β-Eliminative releasable linkers adapted for bioconjugation of macromolecules to phenols.Macromolecular prodrug that provides the irinotecan (CPT-11) active-metabolite SN-38 with ultralong half-life, low C(max), and low glucuronide formation.Hydrogel Drug Delivery System Using Self-Cleaving Covalent Linkers for Once-a-Week Administration of Exenatide.A Hydrogel-Microsphere Drug Delivery System That Supports Once-Monthly Administration of a GLP-1 Receptor Agonist.Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.Subcutaneously Administered Self-Cleaving Hydrogel-Octreotide Conjugates Provide Very Long-Acting Octreotide.
P50
Q27487356-4C9B86A1-8756-4369-8126-26557B7EAC9AQ27650727-E2DF6352-AA97-4861-815B-8652C88A7F11Q27676066-10AAF587-5B42-4208-88B3-EABF7A84596EQ28475558-1ACFFFBA-172F-41AD-BD04-8FD90790066DQ31029294-F9E2EFF6-C0C4-470C-8266-2B30C0184314Q31106557-6720B1B9-B49C-4CB4-A3C0-DBF2A22C49A8Q33432037-433C5B7A-6122-4AB6-971D-A1498F3518F6Q33642336-E7E83504-AA00-4679-9DAE-76344D80106BQ34219669-2933BB9B-21A1-40DB-B50E-810572816D5BQ34809625-F2BA426E-2F37-45CB-B276-18F7857FF818Q35224818-EEAD31CA-CE1A-484E-9081-632BA8493FB9Q35611191-894265CE-9A1E-44E7-BA26-9373704268BCQ38331914-D74F7D7F-EA79-480F-A2B3-0B0F3F49686AQ44420373-D5066FB4-C407-4561-95BF-0D225C85BDEDQ44913074-E411287D-EBA6-4ABE-BFDD-CBCCFCA08D22Q46078856-E3593D8F-FC49-424E-AB2D-2E2237B6E161Q46112658-FFCD9F3E-075E-4B7F-B9F3-BCCE987FF440Q50880432-FA065953-838F-4EF7-B04E-1661C04C87E4Q51307415-A3D2ABB4-142A-41D5-A178-2F5CB3862CB1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eric Schneider
@ast
Eric Schneider
@en
Eric Schneider
@es
Eric Schneider
@nl
Eric Schneider
@sl
Эрик Шнайдер
@ru
type
label
Eric Schneider
@ast
Eric Schneider
@en
Eric Schneider
@es
Eric Schneider
@nl
Eric Schneider
@sl
Эрик Шнайдер
@ru
altLabel
Eric L. Schneider
@en
prefLabel
Eric Schneider
@ast
Eric Schneider
@en
Eric Schneider
@es
Eric Schneider
@nl
Eric Schneider
@sl
Эрик Шнайдер
@ru
P106
P21
P31
P496
0000-0001-7274-7961